Zobrazeno 1 - 10
of 539
pro vyhledávání: '"D M, Pritchard"'
Autor:
Crowley, Jason
Publikováno v:
Hermathena, 2011 Jul 01(190), 134-138.
Externí odkaz:
https://www.jstor.org/stable/42951019
Autor:
F. Jardi, C. Kelly, C. Teague, H. Fowler-Williams, D. C. Sevin, D. Rodrigues, H. Jo, S. Ferreira, B. Herpers, M. Van Heerden, T. de Kok, C. Pin, A. Lynch, C. A. Duckworth, S. De Jonghe, L. Lammens, D. M. Pritchard
Publikováno v:
Archives of Toxicology, 97(1), 235-254. Springer
Archives of Toxicology
Archives of Toxicology
Cross-species comparison of drug responses at the organoid level could help to determine the human relevance of findings from animal studies. To this end, we first need to evaluate the in vitro to in vivo translatability of preclinical organoids. Her
Autor:
F, Jardi, C, Kelly, C, Teague, H, Fowler-Williams, D C, Sevin, D, Rodrigues, H, Jo, S, Ferreira, B, Herpers, M, Van Heerden, T, de Kok, C, Pin, A, Lynch, C A, Duckworth, S, De Jonghe, L, Lammens, D M, Pritchard
Publikováno v:
Archives of toxicology.
Cross-species comparison of drug responses at the organoid level could help to determine the human relevance of findings from animal studies. To this end, we first need to evaluate the in vitro to in vivo translatability of preclinical organoids. Her
Publikováno v:
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland
AIM:Recent data have suggested near-equivalent oncological results when treating early rectal cancer by local excision followed by radio +/- chemotherapy rather than salvage radical surgery. The aim of this retrospective study was to assess the use o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8b5664e956ba8edc2d7af726b88b8d
Autor:
A. Sun Myint, D. M. Pritchard, Alexandra J. Stewart, Thanos Athanasiou, Christopher Rao, Brendan Collins, Antony P. Martin
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 30(10)
Aims Emerging evidence suggests that contact X-ray brachytherapy (CXB) may increase the clinical complete response rate and durability when administered after standard chemoradiotherapy in patients with rectal cancer. The addition of CXB in partial r
Publikováno v:
British Journal of Cancer
(131)I-metaiodobenzylguanidine ((131)I-MIBG) is a licensed palliative treatment for patients with metastatic neuroendocrine tumours. We have retrospectively assessed the consequences of (131)I-MIBG therapy in 48 patients (30 gastroenteropancreatic, 6
Publikováno v:
Toxicology Letters. :19-27
The relationship between toxin-induced apoptosis and longer-term (>72 h) intestinal toxicity was investigated in vivo using p53 wild type ( +/+ ) and `knockout' ( −/− ) mice. The enterotoxic antimetabolite 5-fluorouracil (5-FU) induced acute p53-
Autor:
Sorina Radulescu, Satish Patel, Richard Poulsom, Owen J. Sansom, D. M. Pritchard, P. Salgueiro, Dimitris Athineos, Andreas Jung, Jens Neumann, James R. Woodgett, Nick Barker, Karin A. Oien, Rachel A. Ridgway, Julia B. Cordero
Publikováno v:
Oncogene
A role for WNT signalling in gastric carcinogenesis has been suggested due to two major observations. First, patients with germline mutations in adenomatous polyposis coli (APC) are susceptible to stomach polyps and second, in gastric cancer, WNT act
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::956160a94ec2ad3fd1c8091f76a443d3
https://eprints.gla.ac.uk/80089/1/80089.pdf
https://eprints.gla.ac.uk/80089/1/80089.pdf
Letter: are idiopathic (non-NSAID, non-Helicobacter pylori) ulcers really increasing? Authors’ reply
Publikováno v:
Alimentary Pharmacology & Therapeutics. 36:601-602
Autor:
A, Sobrero, D, Kerr, B, Glimelius, E, Van Cutsem, G, Milano, D M, Pritchard, P, Rougier, M, Aapro
Publikováno v:
European journal of cancer (Oxford, England : 1990). 36(5)
Today, adjuvant 5-fluorouracil based therapy is known to significantly reduce the relapse rates and the risks of dying from resected colon cancer; chemotherapy approximately doubles overall survival of advanced colorectal cancer and second line treat